Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

Science. 1999 Feb 5;283(5403):857-60. doi: 10.1126/science.283.5403.857.

Abstract

Clinical evidence suggests that cellular immunity is involved in controlling human immunodeficiency virus-1 (HIV-1) replication. An animal model of acquired immune deficiency syndrome (AIDS), the simian immunodeficiency virus (SIV)-infected rhesus monkey, was used to show that virus replication is not controlled in monkeys depleted of CD8+ lymphocytes during primary SIV infection. Eliminating CD8+ lymphocytes from monkeys during chronic SIV infection resulted in a rapid and marked increase in viremia that was again suppressed coincident with the reappearance of SIV-specific CD8+ T cells. These results confirm the importance of cell-mediated immunity in controlling HIV-1 infection and support the exploration of vaccination approaches for preventing infection that will elicit these immune responses.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / immunology
  • Acquired Immunodeficiency Syndrome / virology
  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Viral / blood
  • CD8-Positive T-Lymphocytes / immunology*
  • Disease Progression
  • Gene Products, gag / blood
  • Humans
  • Lymphocyte Count
  • Lymphocyte Depletion
  • Macaca mulatta
  • Neutralization Tests
  • RNA, Viral / blood
  • Simian Acquired Immunodeficiency Syndrome / immunology*
  • Simian Acquired Immunodeficiency Syndrome / virology*
  • Simian Immunodeficiency Virus / immunology*
  • Simian Immunodeficiency Virus / physiology
  • T-Lymphocytes, Cytotoxic / immunology
  • Time Factors
  • Viral Load
  • Viremia / immunology
  • Viremia / virology
  • Virus Replication

Substances

  • Antibodies, Monoclonal
  • Antibodies, Viral
  • Gag protein p27, Simian immunodeficiency virus
  • Gene Products, gag
  • RNA, Viral